Ana Beloqui

机构：Ikerbasque, University of the Basque Country, Polymat, International Drug Development Institute (Belgium), Walloon Excellence in Lifesciences and Biotechnology, UCLouvain · ORCID：0000-0003-4221-3357

发表论文 67 篇 · 总被引 4112 次 · h-index 32

代表论文

Nonalcoholic fatty liver disease: Current therapies and future perspectives in drug delivery (2023 · Journal of Controlled Release · 被引 41)
Oral nanomedicine biointeractions in the gastrointestinal tract in health and disease (2023 · Advanced Drug Delivery Reviews · 被引 28)
A nanoparticle platform for combined mucosal healing and immunomodulation in inflammatory bowel disease treatment (2023 · Bioactive Materials · 被引 27)
Impact of metformin and Dysosmobacter welbionis on diet-induced obesity and diabetes: from clinical observation to preclinical intervention (2023 · Diabetologia · 被引 26)
“Green” synthesized versus chemically synthesized zinc oxide nanoparticles: In vivo antihyperglycemic activity and pharmacokinetics (2023 · International Journal of Pharmaceutics · 被引 21)
Exploiting the biological effect exerted by lipid nanocapsules in non-alcoholic fatty liver disease (2023 · Journal of Controlled Release · 被引 21)